Cargando…
The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia
INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044731/ https://www.ncbi.nlm.nih.gov/pubmed/35525158 http://dx.doi.org/10.1016/j.ajem.2022.04.036 |
_version_ | 1784695166988189696 |
---|---|
author | Satici, Merve Osoydan Islam, Mehmet Muzaffer Satici, Celal Uygun, Cemre Nur Ademoglu, Enis Altunok, İbrahim Aksel, Gokhan Eroglu, Serkan Emre |
author_facet | Satici, Merve Osoydan Islam, Mehmet Muzaffer Satici, Celal Uygun, Cemre Nur Ademoglu, Enis Altunok, İbrahim Aksel, Gokhan Eroglu, Serkan Emre |
author_sort | Satici, Merve Osoydan |
collection | PubMed |
description | INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients with COVID-19 and its prognostic utility in combination with a noninvasive score ‘CRB-65’. METHODS: A retrospective study was performed in a tertiary training and research hospital, which included 272 patients with COVID-19 pneumonia diagnosed with polymerase chain reaction in emergency department. Data on characteristics, vital signs, and laboratory parameters were recorded from electronic medical records. The primary outcome of the study was 30-day mortality, and we assessed the discriminative ability of SpO2/FiO2 in predicting mortality in patients with COVID-19 pneumonia and its prognostic utility in combination with conventional pneumonia risk assessment scores. RESULTS: Multivariate analysis revealed that only SpO2/FiO2 level was found to be an independent parameter associated with 30-day mortality (OR:0.98, 95% CI: 0.98–0.99, p = 0.003). PSI and CURB-65 were found to be better scores than CRB-65 in predicting 30-day mortality (AUC: 0.79 vs 0.72, p = 0.04; AUC: 0.76 vs 0.72, p = 0.01 respectively). Both SpO2/FiO2 combined with CRB-65 and SpO2/FiO2 combined with CURB-65 have good discriminative ability and seemed to be more favorable than PSI in predicting 30-days mortality (AUC: 0.83 vs 0.75; AUC: 0.84 vs 0.75), however no significant difference was found (p = 0.21 and p = 0.06, respectively). CONCLUSION: SpO2/FiO2 is a promising index in predicting mortality. Addition of SpO2/FiO2 to CRB-65 improved the role of CRB-65 alone, however it performed similar to PSI. The combined noninvasive model of SpO2/FiO2 and CRB-65 may help physicians quickly stratify COVID-19 patients on admission, which is expected to be particularly important in hospitals still stressed by pandemic volumes. |
format | Online Article Text |
id | pubmed-9044731 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90447312022-04-28 The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia Satici, Merve Osoydan Islam, Mehmet Muzaffer Satici, Celal Uygun, Cemre Nur Ademoglu, Enis Altunok, İbrahim Aksel, Gokhan Eroglu, Serkan Emre Am J Emerg Med Article INTRODUCTION: Noninvasive risk assessment is crucial in patients with COVID-19 in emergency department. Since limited data is known about the role of noninvasive parameters, we aimed to evaluate the role of a noninvasive parameter ‘SpO2/FiO2’ in independently predicting 30-day mortality in patients with COVID-19 and its prognostic utility in combination with a noninvasive score ‘CRB-65’. METHODS: A retrospective study was performed in a tertiary training and research hospital, which included 272 patients with COVID-19 pneumonia diagnosed with polymerase chain reaction in emergency department. Data on characteristics, vital signs, and laboratory parameters were recorded from electronic medical records. The primary outcome of the study was 30-day mortality, and we assessed the discriminative ability of SpO2/FiO2 in predicting mortality in patients with COVID-19 pneumonia and its prognostic utility in combination with conventional pneumonia risk assessment scores. RESULTS: Multivariate analysis revealed that only SpO2/FiO2 level was found to be an independent parameter associated with 30-day mortality (OR:0.98, 95% CI: 0.98–0.99, p = 0.003). PSI and CURB-65 were found to be better scores than CRB-65 in predicting 30-day mortality (AUC: 0.79 vs 0.72, p = 0.04; AUC: 0.76 vs 0.72, p = 0.01 respectively). Both SpO2/FiO2 combined with CRB-65 and SpO2/FiO2 combined with CURB-65 have good discriminative ability and seemed to be more favorable than PSI in predicting 30-days mortality (AUC: 0.83 vs 0.75; AUC: 0.84 vs 0.75), however no significant difference was found (p = 0.21 and p = 0.06, respectively). CONCLUSION: SpO2/FiO2 is a promising index in predicting mortality. Addition of SpO2/FiO2 to CRB-65 improved the role of CRB-65 alone, however it performed similar to PSI. The combined noninvasive model of SpO2/FiO2 and CRB-65 may help physicians quickly stratify COVID-19 patients on admission, which is expected to be particularly important in hospitals still stressed by pandemic volumes. Elsevier Inc. 2022-07 2022-04-27 /pmc/articles/PMC9044731/ /pubmed/35525158 http://dx.doi.org/10.1016/j.ajem.2022.04.036 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Satici, Merve Osoydan Islam, Mehmet Muzaffer Satici, Celal Uygun, Cemre Nur Ademoglu, Enis Altunok, İbrahim Aksel, Gokhan Eroglu, Serkan Emre The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title | The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title_full | The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title_fullStr | The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title_full_unstemmed | The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title_short | The role of a noninvasive index ‘Spo2/ Fio2’ in predicting mortality among patients with COVID-19 pneumonia |
title_sort | role of a noninvasive index ‘spo2/ fio2’ in predicting mortality among patients with covid-19 pneumonia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044731/ https://www.ncbi.nlm.nih.gov/pubmed/35525158 http://dx.doi.org/10.1016/j.ajem.2022.04.036 |
work_keys_str_mv | AT saticimerveosoydan theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT islammehmetmuzaffer theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT saticicelal theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT uyguncemrenur theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT ademogluenis theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT altunokibrahim theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT akselgokhan theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT erogluserkanemre theroleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT saticimerveosoydan roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT islammehmetmuzaffer roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT saticicelal roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT uyguncemrenur roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT ademogluenis roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT altunokibrahim roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT akselgokhan roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia AT erogluserkanemre roleofanoninvasiveindexspo2fio2inpredictingmortalityamongpatientswithcovid19pneumonia |